Invention Grant
- Patent Title: Cell-permeable Cre (iCP-Cre) recombinant protein and use thereof
-
Application No.: US15887414Application Date: 2018-02-02
-
Publication No.: US10669531B2Publication Date: 2020-06-02
- Inventor: Daewoong Jo
- Applicant: CELLIVERY THERAPEUTICS, INC.
- Applicant Address: KR Seoul
- Assignee: CELLIVERY THERAPEUTICS, INC.
- Current Assignee: CELLIVERY THERAPEUTICS, INC.
- Current Assignee Address: KR Seoul
- Agency: Sughrue Mion, PLLC
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C12N9/12 ; C07K7/08 ; C12N9/00
Abstract:
The iCP-Cre recombinant protein of the present invention could mediate inactivation of a target genes, it may be used for the production of a conditional knockout mouse and be applied to investigation of the function and activation of the gene.
Public/Granted literature
- US20180230444A1 CELL-PERMEABLE CRE (ICP-CRE) RECOMBINANT PROTEIN AND USE THEREOF Public/Granted day:2018-08-16
Information query
